Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-74.27	29.32	113.96
Graham Fair Price	42.81	6.64	4.65
PEG	-40.43	-0.28	0.46
Price/Book	-19.07	1.66	2.06
Price/Cash Flow	-34.06	95.66	145.07
Prices/Earnings	59.54	-27.67	-68.39
Price/Sales	-59.54	3.25	8.03
Price/FCF	-34.06	95.66	145.07
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.32	0.32
Operating Margin	-57.69	< 0.005	0.01
ROA	-100.00	< 0.005	< 0.005
ROE	< 0.005	-0.02	-100.00
ROIC	< 0.005	< 0.005	-16.27
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.02	0.08	-67.94
Dividends QOQ	-0.11	< 0.005	-90.92
EBIT QOQ	-0.89	-0.15	82.73
EPS QOQ	-1.47	-1.00	32.08
FCF QOQ	2.35	0.23	-90.32
Revenue QOQ	-0.52	1.00	92.55
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	97.74	48.87	-50.00
Days Sales Outstanding (DSO)	43.85	31.25	-28.74
Inventory Turnover	0.92	1.84	100.00
Debt/Capitalization	0.42	0.43	1.42
Quick Ratio	1.06	1.07	1.22
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	11.30	11.41	0.98
Cash	3.17	2.65	-16.34
Capex	-0.33	-0.80	-139.41
Free Cash Flow	0.16	0.20	23.93
Revenue	2.90	5.85	101.96
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.73	1.73	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	20.55	6.46	-68.54
Naive Interpretation	Member

06 - Financial Health · Weak

Rating